510(k) Report

510(k) · Cleared

Cleared

Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/ Clever Chek TD-3250 Blood Glucose Plus Blo

K062800510(k) TraditionalCleared Jan 12, 2007115-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Taidoc Technology Corporation · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Jan 12, 2007 as substantially equivalent to K061181 (Taidoc Technology Corporation, 2006) and 2 other predicates after a 115-day review. Its family tree reaches back 3 generations to 2002. 2 later devices descend from it.

Decided
Jan 12, 2007
Review
115 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K021239 (2002). 8 ancestors in all, the oldest K012636 (2001). 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 2 other ancestors2004: 1 other ancestor2002: 1 other ancestor2001: 1 other ancestor2010: 1 descendant cleared2008: 1 descendant clearedK021239 · Eikon Automatic Digital Blood Pressure Monitor, Model HD-400M · Eikon Healthcare Device Corp. · 2002K040159 · Apm Blood Pressure Monitor, Model BP108A · Asia Pacific Microsystems, Inc. · 2004K042795 · Clever Chek TD-3213 · Taidoc Technology Corporation · 2005200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 3 other ancestors 1 generation forward: 2 descendants K042795 · Clever Chek TD-3213 · Taidoc Technology Corporation · 2005K040159 · Apm Blood Pressure Monitor, Model BP108A · Asia Pacific Microsystems, Inc. · 2004K021239 · Eikon Automatic Digital Blood Pressure Monitor, Model HD-400M · Eikon Healthcare Device Corp. · 20020
  1. Root · 3 generations backK021239 Eikon Automatic Digital Blood Pressure Monitor, Model HD-400MEikon Healthcare Device Corp. · 2002
  2. 2 generations backK040159 Apm Blood Pressure Monitor, Model BP108AAsia Pacific Microsystems, Inc. · 2004
  3. 1 generation backK042795 Clever Chek TD-3213Taidoc Technology Corporation · 2005
  4. This deviceK062800 Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek…Taidoc Technology Corporation · 2007
  5. Descendant · cites it directly · 0 of its ownK092875 Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation · 2010
  6. Descendant · cites it directly · 0 of its ownK080014 Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring…Taidoc Technology Corporation · 2008

Most influential descendants

Showing 2 of 2 · See all
  • K092875Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation · 2010 · cites it directly0descendants
  • K080014Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring SystemTaidoc Technology Corporation · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K021239Eikon Automatic Digital Blood Pressure Monitor, Model HD-400MEikon Healthcare Device Corp.2002—
−2K040159Apm Blood Pressure Monitor, Model BP108AAsia Pacific Microsystems, Inc.2004—
−1K042795Clever Chek TD-3213Taidoc Technology Corporation2005—
0 (this device)K062800Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/…Taidoc Technology Corporation2007—
+1K092875Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation2010—
+1K080014Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring SystemTaidoc Technology Corporation2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
200410
200620

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201010
FIG. 1 — Lineage of K062800, 2002–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061181Achtung Blood Glucose Monitoring System, Model TD-4207
Summary page 1
…21 CFR Section 862.1345, Glucose Test System 21 CFR Section 870.1130, Non-invasive Blood Pressure Measurement System 3. Predicate Device K061181 ACHTUNG Blood Glucose Monitoring System by TaiDoc Technology Corporation. K042795 Clever Chek TD-321…
Taidoc Technology Corporation2006—
*K042795Clever Chek TD-3213
Summary page 1
…d Pressure Measurement System 3. Predicate Device K061181 ACHTUNG Blood Glucose Monitoring System by TaiDoc Technology Corporation. K042795 Clever Chek TD-3213 Blood Glucose and Blood Pressure Measurement System by TaiDoc Technology Corporation. K…
Taidoc Technology Corporation2005—
*K061073Clever Check TD-3250 Blood Glucose and Blood Pressure Measurement System, Model TD-3250
Summary page 1
…Technology Corporation. K042795 Clever Chek TD-3213 Blood Glucose and Blood Pressure Measurement System by TaiDoc Technology Corporation. K061073 Clever Chek TD-3250 Blood Glucose and Blood Pressure Measurement System by TaiDoc Technology Corporation.…
Taidoc Technology Corporation2006—

Also cleared against K061181: 1 other device →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K092875Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation20100
K080014Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring SystemTaidoc Technology Corporation20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 3 companies; a new generation was cleared every 1.4 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K092875 (Taidoc Technology Corporation, 2010) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K061181.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The Clever Chek TD-3213/ Clever Chek TD-3215/ Dr. T TD-3216/Clever Chek TD-3217/ Clever Chek TD-3250 Blood Glucose plus Blood Pressure Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as…

Read the full statement (223 words)

The Clever Chek TD-3213/ Clever Chek TD-3215/ Dr. T TD-3216/Clever Chek TD-3217/ Clever Chek TD-3250 Blood Glucose plus Blood Pressure Monitoring System is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and the following alternative sites: the palm, the forearm, the upper-arm, the calf and the thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates.

The alternative site testing in the systems can be used only during steady-state blood glucose conditions.

The system is also intended to be used to measure non-invasively the systolic and diastolic blood pressure and pulse rate of an adult individual, over age 16, at home.

For Clever Chek TD-3213/ Clever Chek TD-3215/ Dr. T TD-3216/ Clever Chek TD-3217 system, the blood pressure is measured by using a technique in which an inflatable cuff is wrapped around the wrist. The cuff circumference is limited to 5.25" - 7.75".

For Clever Chek TD-3250 system, the blood pressure is measured by using a technique in which an inflatable cuff is wrapped around the arm. The cuff circumference is limited to 9.4" - 13.8".

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K062800: Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/ Clever Chek TD-3250 Blood Glucose Plus Blo.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062800

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026